Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cance

Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cance

Item
http://www.wikidata.org/entity/Q37423919
Concurrent systemic therapy with radiotherapy for the treatment of poor-risk patients with unresectable stage III non-small-cell lung cancer: a review of the literatureTraditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework.INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancerA phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients.Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy.The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801.Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.The multimodal management of locally advanced N2 non-small cell lung cancer: is there a role for surgical resection? A single institution's experience.Integrative tumor board: a case report and discussion from East-West Cancer Center.Predictive factors for survival and correlation to toxicity in advanced Stage III non-small cell lung cancer patients with concurrent chemoradiation.
P2860

Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cance

Item
http://www.wikidata.org/entity/Q37423919
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment outcomes of differen ...... III non-small cell lung cance
@en
Treatment outcomes of differen ...... III non-small cell lung cance
@nl
type
label
Treatment outcomes of differen ...... III non-small cell lung cance
@en
Treatment outcomes of differen ...... III non-small cell lung cance
@nl
prefLabel
Treatment outcomes of differen ...... III non-small cell lung cance
@en
Treatment outcomes of differen ...... III non-small cell lung cance
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Treatment outcomes of differen ...... III non-small cell lung cance
@en
P2093
P2860
P304
P31
P356
10.1097/JTO.0B013E3181B27B33
P433
P478
P50
P577
P698
P921
P932